tiprankstipranks
Advanced BioMedical Technologies Inc. (ABMT)
OTHER OTC:ABMT
US Market
ABMT
Advanced BioMedical Technologies
RESEARCH TOOLSreports

Advanced BioMedical Technologies (ABMT) Ratios

10 Followers

Advanced BioMedical Technologies Ratios

ABMT's free cash flow for Q3 2022 was $1.48. For the 2022 fiscal year, ABMT's free cash flow was decreased by $ and operating cash flow was $21.64. See a summary of the company’s cash flow.
Ratios
TTM
Oct 22Oct 21Oct 20Oct 19
Liquidity Ratios
Current Ratio
 0.04 0.04 0.03 0.04 0.02
Quick Ratio
 <0.01 <0.01 0.01 0.03 <0.01
Cash Ratio
 <0.01 <0.01 <0.01 0.03 <0.01
Solvency Ratio
 -0.06 -0.06 -0.08 -0.08 -0.14
Operating Cash Flow Ratio
 -0.09 -0.09 -0.10 0.08 -0.11
Short-Term Operating Cash Flow Coverage
 -0.11 -0.11 -0.12 0.14 -0.15
Net Current Asset Value
$ -8.04M$ -8.04M$ -8.53M$ -7.54M$ -6.58M
Leverage Ratios
Debt-to-Assets Ratio
 17.21 17.21 15.36 10.10 22.50
Debt-to-Equity Ratio
 -0.86 -0.86 -0.82 -0.64 -0.76
Debt-to-Capital Ratio
 -6.05 -6.05 -4.61 -1.78 -3.15
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 -0.05 -0.05 -0.05 -0.06 -0.03
Debt Service Coverage Ratio
 -0.02 -0.02 -0.05 -0.06 -0.11
Interest Coverage Ratio
 -0.54 -0.54 -1.23 -1.36 -1.85
Debt to Market Cap
 136.22 1.93 1.40 0.45 1.18
Interest Debt Per Share
 0.10 0.10 0.10 0.07 0.08
Net Debt to EBITDA
 -41.00 -41.00 -18.65 -16.06 -8.17
Profitability Margins
Gross Profit Margin
81.88%81.88%54.50%58.07%34.84%
EBIT Margin
-68.23%-68.23%-238.75%-277.59%-5339.37%
EBITDA Margin
-61.26%-61.26%-214.63%-228.74%-5157.97%
Operating Profit Margin
-66.38%-66.38%-230.65%-361.38%-5187.77%
Pretax Profit Margin
-190.22%-190.22%-426.10%-543.75%-8139.49%
Net Profit Margin
-190.22%-190.22%-426.10%-543.75%-8139.49%
Continuous Operations Profit Margin
-190.22%-190.22%-426.10%-543.75%-8139.49%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
286.57%286.57%184.73%150.46%156.90%
Return on Assets (ROA)
-130.27%-130.27%-162.58%-143.21%-434.24%
Return on Equity (ROE)
6.32%6.50%8.70%9.08%14.65%
Return on Capital Employed (ROCE)
2.27%2.27%4.71%6.04%9.33%
Return on Invested Capital (ROIC)
15.99%15.99%26.41%16.78%38.73%
Return on Tangible Assets
-130.27%-130.27%-162.58%-143.21%-434.24%
Earnings Yield
-1460.18%-14.60%-14.84%-6.41%-22.71%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 0.00 4.22 0.23
Payables Turnover
 176.66 176.66 32.15 221.44 3.05
Inventory Turnover
 0.20 0.20 0.41 0.52 0.12
Fixed Asset Turnover
 2.63 2.63 1.17 0.89 0.12
Asset Turnover
 0.68 0.68 0.38 0.26 0.05
Working Capital Turnover Ratio
 -0.03 -0.03 -0.02 -0.02 >-0.01
Cash Conversion Cycle
 1.84K 1.84K 873.27 789.35 4.52K
Days of Sales Outstanding
 0.00 0.00 0.00 86.42 1.56K
Days of Inventory Outstanding
 1.84K 1.84K 884.62 704.59 3.08K
Days of Payables Outstanding
 2.07 2.07 11.35 1.65 119.79
Operating Cycle
 1.84K 1.84K 884.62 791.00 4.64K
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.01 -0.01 -0.01 <0.01 -0.01
Free Cash Flow Per Share
 -0.01 -0.01 -0.01 <0.01 -0.01
CapEx Per Share
 0.00 0.00 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.06 0.95 1.03
Dividend Paid and CapEx Coverage Ratio
 0.00 0.00 -16.41 21.06 -40.00
Capital Expenditure Coverage Ratio
 0.00 0.00 -16.41 21.06 -40.00
Operating Cash Flow Coverage Ratio
 -0.11 -0.11 -0.12 0.14 -0.15
Operating Cash Flow to Sales Ratio
 -2.71 -2.71 -4.94 5.23 -63.70
Free Cash Flow Yield
-1469.06%-20.81%-18.25%5.87%-18.22%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.07 -6.85 -6.74 -15.61 -4.40
Price-to-Sales (P/S) Ratio
 0.18 13.03 28.72 84.89 358.37
Price-to-Book (P/B) Ratio
 >-0.01 -0.44 -0.59 -1.42 -0.64
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.07 -4.81 -5.48 17.03 -5.49
Price-to-Operating Cash Flow Ratio
 -0.05 -4.81 -5.81 16.22 -5.63
Price-to-Earnings Growth (PEG) Ratio
 >-0.01 0.23 -0.81 3.90 0.16
Price-to-Fair Value
 >-0.01 -0.44 -0.59 -1.42 -0.64
Enterprise Value Multiple
 -41.30 -62.27 -32.03 -53.17 -15.12
Enterprise Value
 6.86M 10.34M 11.77M 15.03M 9.09M
EV to EBITDA
 -41.30 -62.27 -32.03 -53.17 -15.12
EV to Sales
 25.30 38.14 68.75 121.62 779.67
EV to Free Cash Flow
 -9.33 -14.07 -13.12 24.40 -11.94
EV to Operating Cash Flow
 -9.33 -14.07 -13.92 23.24 -12.24
Tangible Book Value Per Share
 -0.11 -0.11 -0.12 -0.11 -0.09
Shareholders’ Equity Per Share
 -0.11 -0.11 -0.12 -0.11 -0.09
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Net Income Per Share
 >-0.01 >-0.01 -0.01 >-0.01 -0.01
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 2.79 2.79 1.78 1.96 1.52
Research & Development to Revenue
 0.69 0.69 1.34 1.48 22.62
SG&A to Revenue
 0.80 0.00 0.00 2.23 27.80
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 1.42 1.42 1.16 -0.96 0.78
Currency in USD